The University of Oxford in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI) has begun a new clinical trial called TB045, which aims to test tuberculosis (TB) vaccine safety and the host...
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with “kill switches” that can be triggered to stop the bacteria...
An “unconventional” immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB)...
In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach. TB remains the leading cause of death by infectious disease globally, with South...
Chasing India’s target of eliminating tuberculosis by 2025, scientists at the Indian Council of Medical Research have recruited about 12,000 participants for a phase III study of two potential vaccines. The researchers...
Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a...
An experimental tuberculosis (TB) vaccine could prevent people who have TB with no sign of illness from progressing to TB of the lungs for up to three years, potentially saving millions of lives, a study shows. The WHO...
Tuberculosis (TB) is a leading killer of people with HIV, and providing therapy for both illnesses simultaneously saves lives – according to new guidelines on the treatment of drug-susceptible TB developed jointly...
Doctors Without Borders (MSF) released a new publication of DR-TB Drugs Under the Microscope, showing that just 2 percent out of the 150,000 people with drug-resistant tuberculosis have access to the new, better...
Researchers from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing have found tuberculin skin testing may be overestimating the prevalence of latent tuberculosis in China. They suggest...